Genetic Diversity of Multidrug-Resistant Pseudomonas aeruginosa Isolates Carrying blaVIM–2 and blaKPC–2 Genes That Spread on Different Genetic Environment in Colombia

Autores organización
Autores
- Rada AM
- Agudelo CA
- Restrepo E
- Correa A
- Capataz C
Grupos de investigación
Resumen
Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen with an increase in the frequency of infections caused by multidrug resistant (MDR) and extensively drug resistant (XDR) strains, limiting the available therapeutic options. The most troublesome resistance is the acquisition and production of carbapenemases such as Verona integron-encoded metallo-ß-lactamases (VIM), the most frequent and widespread, and the Klebsiella pneumoniae carbapenemases (KPC), which has continuously spread in the last decade. Its dissemination is linked to their location on mobile genetic elements (MGEs). In Colombia, VIM and KPC have been increasing in its frequency showing major successful dissemination. In this article, we molecularly characterized and analyzed the genetic context of blaVIM and blaKPC in carbapenem-resistant P. aeruginosa (CRPA) isolates from infected and colonized patients in two tertiary-care hospitals, one in Medellín and the other in a municipality close to Medellín, both areas with high carbapenemase endemicity in Colombia (2013–2015). Using whole-genome sequencing (WGS), we identified a remarkable variety of genetic backgrounds in these MDR P. aeruginosa isolates carrying blaKPC–2 and blaVIM–2. There were a diversity of class 1 integron and variations in the gene cassettes associated to blaVIM–2, as well as a possible event of spread of blaKPC–2 mediated by a plasmid that contained part of Tn4401b in one infection case. The dissemination of blaVIM–2 and blaKPC–2 in P. aeruginosa in this area in Colombia has been strongly influenced by successful international clones, carrying these genes and additional determinants of resistance on MGEs, accompanied by gene rearrangement under an antimicrobial selection pressure. These findings emphasize the need to implement control strategies based on rational antibiotic use. © Copyright © 2021 Rada, De La Cadena, Agudelo, Pallares, Restrepo, Correa, Villegas and Capataz.
Copyright © 2021 Rada, De La Cadena, Agudelo, Pallares, Restrepo, Correa, Villegas and Capataz.
Datos de la publicación
- ISSN/ISSNe:
- 1664-302X, 1664-302X
- Tipo:
- Article
- Páginas:
- 663020-663020
- PubMed:
- 34512563
- Enlace a otro recurso:
- www.scopus.com
Frontiers In Microbiology Frontiers Media S.A.
Citas Recibidas en Web of Science: 10
Citas Recibidas en Scopus: 20
Documentos
- No hay documentos
Filiaciones
Keywords
- beta lactamase; carbapenemase; cefepime; ceftazidime; DNA topoisomerase; DNA topoisomerase (ATP hydrolysing); doripenem; gentamicin; imipenem; meropenem; metallo beta lactamase; piperacillin plus tazobactam; rifampicin; amino acid substitution; antibiotic sensitivity; Article; bone development; clinical article; controlled study; diabetes mellitus; DNA extraction; DNA sequencing; genetic variability; human; hypertension; Klebsiella pneumoniae; male; minimum inhibitory concentration; phylogenetic tree; phylogeny; Pseudomonas aeruginosa; rectal swab; tertiary care center; whole genome sequencing
Campos de Estudio
Proyectos asociados
Creating a Latin America network for clinical training and support of pharmacists and hospital financial decision makers involved in ASPs
Investigador Principal: MARIA VIRGINIA VILLEGAS BOTERO
UEB-2020-585 . 2020
Caracterización Molecular de Aislamientos Resistentes a Ceftazidime Avibactam en Enterobacterales y Pseudomonas aeruginosa recolectados en cinco Países de América Latina. Molecular mechanisms leading to ceftazidime-avibactam resistance in Enterobacterales and Pseudomonas aeruginosa collected from five Latin American countries
Investigador Principal: MARIA VIRGINIA VILLEGAS BOTERO
UEB-2020-586 . 2020